EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Targeted siRNA Delivery Against RUNX1 Via tFNA: Inhibiting Retinal Neovascularization and Restoring Vessels Through Dll4/Notch1 Signaling

Xiaodi Zhou, Xiaoxiao Xu, Qiong Wang, Yanting Lai, Linyan Zhang, Yunfeng Lin, Xiaoyan Ding, Limei Sun

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.3.39 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Xiaodi Zhou and 7 co-authors. Institution: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Major MEDLINE topics: Retinal Neovascularization, Receptor, Notch1, RNA, Small Interfering, Intracellular Signaling Peptides and Proteins. 40 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Purpose: To assess the efficacy of tetrahedral framework nucleic acids (tFNAs) as a delivery system for small interfering RNA (siRNA) targeting RUNX1 (siRUNX1) in inhibiting retinal neovascularization (RNV) and restoring vascular integrity via the Dll4/Notch1 signaling pathway. Methods: tFNAs and tFNAs-siRUNX1 were synthesized using annealing of single-stranded DNAs and characterized by PAGE and high-performance capillary electrophoresis. Human umbilical vein endothelial cells were treated under hypoxic conditions with tFNAs-siRUNX1, and cellular uptake was evaluated using fluorescence microscopy and flow cytometry. Angiogenesis was assessed through EdU proliferation, tube formation, and wound-healing assays. In vivo experiments used oxygen-induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV) models in mice, with subsequent imaging by optical coherence tomography (OCT) and fundus fluorescence angiography. Gene and protein expression were analyzed by RT-PCR and Western blotting, focusing on the Dll4/Notch1 pathway and apoptosis markers. Results: tFNAs-siRUNX1 effectively inhibited endothelial cell proliferation, migration, and tube formation in vitro. In OIR and CNV models, it reduced neovascularization, nonperfusion areas, and vascular leakage. The mechanism involved modulation of the Dll4/Notch1 pathway, with decreased Dll4, Notch1, and Hes1 and increased Nts expression. tFNAs-siRUNX1 also reduced endothelial cell apoptosis via the Bcl-2/Bax pathway. Conclusions: tFNAs-siRUNX1 is a promising delivery system for targeting RNV, inhibiting neovascularization, and restoring retinal vascular integrity, providing a potential therapeutic alternative to anti-VEGF treatments.

Subjects

MeSH terms (MEDLINE)

Retinal NeovascularizationReceptor, Notch1RNA, Small InterferingIntracellular Signaling Peptides and ProteinsAnimalsHumansMiceSignal TransductionDisease Models, AnimalHuman Umbilical Vein Endothelial CellsFluorescein AngiographyCell ProliferationMice, Inbred C57BLBlotting, WesternCalcium-Binding ProteinsCells, CulturedTomography, Optical CoherenceAdaptor Proteins, Signal TransducingFlow CytometryApoptosisRetinal VesselsChoroidal NeovascularizationCell MovementMale

Substances

Receptor, Notch1RNA, Small InterferingDLL4 protein, humanCalcium-Binding ProteinsAdaptor Proteins, Signal TransducingNOTCH1 protein, humanRUNX1 protein, humanIntracellular Signaling Peptides and ProteinsCore Binding Factor Alpha 2 Subunit

Authors and institutions

  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.
  • Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Department of Maxillofacial Surgery, West China Stomatological Hospital, Sichuan University, Chengdu, China.

Cite

APA

Zhou, X., Xu, X., Wang, Q., Lai, Y., Zhang, L., Lin, Y., Ding, X., & Sun, L. (2025). Targeted siRNA Delivery Against RUNX1 Via tFNA: Inhibiting Retinal Neovascularization and Restoring Vessels Through Dll4/Notch1 Signaling. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.3.39

Vancouver

Zhou X, Xu X, Wang Q, Lai Y, Zhang L, Lin Y, et al. Targeted siRNA Delivery Against RUNX1 Via tFNA: Inhibiting Retinal Neovascularization and Restoring Vessels Through Dll4/Notch1 Signaling. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.3.39

BibTeX
@article{Zhou2025,
  author = {Zhou, Xiaodi and Xu, Xiaoxiao and Wang, Qiong and Lai, Yanting and Zhang, Linyan and Lin, Yunfeng and Ding, Xiaoyan and Sun, Limei},
  title = {Targeted siRNA Delivery Against RUNX1 Via tFNA: Inhibiting Retinal Neovascularization and Restoring Vessels Through Dll4/Notch1 Signaling},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.3.39}
}
Start for free →